Mazidi, M.; Katsiki, N.; Mikhailidis, D.P.; Radenkovic, D.; Pella, D.; Banach, M., on behalf of the International Lipid Expert Panel (ILEP).
Apolipoprotein B/Apolipoprotein A-I Ratio Is a Better Predictor of Cancer Mortality Compared with C-Reactive Protein: Results from Two Multi-Ethnic US Populations. J. Clin. Med. 2020, 9, 170.
https://doi.org/10.3390/jcm9010170
AMA Style
Mazidi M, Katsiki N, Mikhailidis DP, Radenkovic D, Pella D, Banach M on behalf of the International Lipid Expert Panel (ILEP).
Apolipoprotein B/Apolipoprotein A-I Ratio Is a Better Predictor of Cancer Mortality Compared with C-Reactive Protein: Results from Two Multi-Ethnic US Populations. Journal of Clinical Medicine. 2020; 9(1):170.
https://doi.org/10.3390/jcm9010170
Chicago/Turabian Style
Mazidi, Mohsen, Niki Katsiki, Dimitri P. Mikhailidis, Dina Radenkovic, Daniel Pella, and Maciej Banach on behalf of the International Lipid Expert Panel (ILEP).
2020. "Apolipoprotein B/Apolipoprotein A-I Ratio Is a Better Predictor of Cancer Mortality Compared with C-Reactive Protein: Results from Two Multi-Ethnic US Populations" Journal of Clinical Medicine 9, no. 1: 170.
https://doi.org/10.3390/jcm9010170
APA Style
Mazidi, M., Katsiki, N., Mikhailidis, D. P., Radenkovic, D., Pella, D., & Banach, M., on behalf of the International Lipid Expert Panel (ILEP).
(2020). Apolipoprotein B/Apolipoprotein A-I Ratio Is a Better Predictor of Cancer Mortality Compared with C-Reactive Protein: Results from Two Multi-Ethnic US Populations. Journal of Clinical Medicine, 9(1), 170.
https://doi.org/10.3390/jcm9010170